As IDH-1 mutation status distinguishes more aggressive GBs from other HGGs, we wondered if the time-to-recurrence increase in Hispanic patients could be explained by increased IDH-1 mutated (non-GB) tumors in this group. This evidence concerns the gene IDH1 and Guillain-Barre syndrome.